PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
24-Sep-2020 ICR and Cancer Research UK spinout company Monte Rosa Therapeutics raises $96m in ‘Series B’ Financing ICR and Cancer Research UK
24-Sep-2020 Algenex inaugurates new facility with capacity to produce up to 100 million vaccine doses Algenex SL
24-Sep-2020 Coeliac UK wins national award for its Gluten Free on the Move app - winning the category for the second year in a row Coeliac UK
24-Sep-2020 Vifor Pharma announces outcome of AFFIRM-AHF topline data Vifor Pharma
24-Sep-2020 GLEAMER raises € 7.5 million to market A.I. platform offering radiologists semi-automated diagnosis of medical images GLEAMER
24-Sep-2020 MMS and Pharmacy Automation is Easing the Pressure During COVID-19 Becton, Dickinson and Company
24-Sep-2020 JanOne Successfully Begins Production of JAN101 cGMP Batch for Phase 2b Peripheral Artery Disease (PAD) Trial and Potential Covid-19 Study JanOne Inc.
24-Sep-2020 Sygnature Discovery expands DMPK capabilities with acquisition of XenoGesis Sygnature Discovery
24-Sep-2020 LifeArc and UK government’s Future Fund provide £3.0m in funding to Avvinity Therapeutics LifeArc
24-Sep-2020 MindMed and Liechti Lab Announce R&D Collaboration On Psilocybin Mind Medicine (MindMed) Inc.
24-Sep-2020 Biotage appoints Nomination Committee Biotage
24-Sep-2020 Accord Healthcare Launches Zercepac®▼ (trastuzumab) biosimilar in the UK Accord Healthcare
24-Sep-2020 Macrogen, K-Quarantine System "Smart Mobile Lab" Exported to Indonesia Macrogen
23-Sep-2020 Luminex Receives BARDA Award to Support Enhancement of COVID-19 Multiplex Antibody Test Luminex Corporation
23-Sep-2020 Seven Bridges Advances Workflow Automation Capabilities to Make Complex Multi-Omic Analysis More Accessible to Broader Mix of Users Seven Bridges
23-Sep-2020 Salvia BioElectronics raises EUR 26M (USD 31M) to develop innovative neurostimulation therapy for chronic migraine Salvia BioElectronics
23-Sep-2020 Aqilion announces identity of drug target and presents novel data from the drug discovery program Alnitak Aqilion
23-Sep-2020 Interim results for the six months ended 30 June 2020 Strong performance from Consumer Healthcare brands; cash generation remains robust; full year results tracking in line with market expectations ALLIANCE PHARMA PLC
23-Sep-2020 Nemaura Medical Licenses Validated Mobile Application to Create Powerful Diabetes Prevention and Management Suite of Products Nemaura Medical, Inc.
23-Sep-2020 Aqualung Therapeutics Corp. Awarded $300K from NIH to Develop A Novel Therapeutic For Pregn Aqualung Therapeutics